These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35251626)

  • 1. Establishment of a patient-derived mucoepidermoid carcinoma cell line with the
    Noguchi K; Kanda S; Yoshida K; Funaoka Y; Yamanegi K; Yoshikawa K; Takaoka K; Kishimoto H; Nakano Y
    Mol Clin Oncol; 2022 Mar; 16(3):75. PubMed ID: 35251626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrantly activated AREG-EGFR signaling is required for the growth and survival of CRTC1-MAML2 fusion-positive mucoepidermoid carcinoma cells.
    Chen Z; Chen J; Gu Y; Hu C; Li JL; Lin S; Shen H; Cao C; Gao R; Li J; Ha PK; Kaye FJ; Griffin JD; Wu L
    Oncogene; 2014 Jul; 33(29):3869-77. PubMed ID: 23975434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of amphiregulin in mucoepidermoid carcinoma of the major salivary glands: a molecular and clinicopathological study.
    Shinomiya H; Ito Y; Kubo M; Yonezawa K; Otsuki N; Iwae S; Inagaki H; Nibu KI
    Hum Pathol; 2016 Nov; 57():37-44. PubMed ID: 27393417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CRTC1-MAML2 fusion is the major oncogenic driver in mucoepidermoid carcinoma.
    Chen Z; Ni W; Li JL; Lin S; Zhou X; Sun Y; Li JW; Leon ME; Hurtado MD; Zolotukhin S; Liu C; Lu J; Griffin JD; Kaye FJ; Wu L
    JCI Insight; 2021 Apr; 6(7):. PubMed ID: 33830080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Pancreatic Mucoepidermoid Carcinoma" Is not a Pancreatic Counterpart of CRTC1/3-MAML2 Fusion Gene-related Mucoepidermoid Carcinoma of the Salivary Gland, and May More Appropriately be Termed Pancreatic Adenosquamous Carcinoma With Mucoepidermoid Carcinoma-like Features.
    Saeki K; Ohishi Y; Matsuda R; Mochidome N; Miyasaka Y; Yamamoto H; Koga Y; Maehara Y; Nakamura M; Oda Y
    Am J Surg Pathol; 2018 Nov; 42(11):1419-1428. PubMed ID: 30138216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression profiling analysis of CRTC1-MAML2 fusion oncogene-induced transcriptional program in human mucoepidermoid carcinoma cells.
    Chen J; Li JL; Chen Z; Griffin JD; Wu L
    BMC Cancer; 2015 Oct; 15():803. PubMed ID: 26503699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological significance of EGFR pathway gene mutations and CRTC1/3-MAML2 fusions in salivary gland mucoepidermoid carcinoma.
    Morita M; Murase T; Okumura Y; Ueda K; Sakamoto Y; Masaki A; Kawakita D; Tada Y; Nibu KI; Shibuya Y; Inagaki H
    Histopathology; 2020 Jun; 76(7):1013-1022. PubMed ID: 32129900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRTC1-MAML2 fusion-induced lncRNA LINC00473 expression maintains the growth and survival of human mucoepidermoid carcinoma cells.
    Chen Z; Lin S; Li JL; Ni W; Guo R; Lu J; Kaye FJ; Wu L
    Oncogene; 2018 Apr; 37(14):1885-1895. PubMed ID: 29353885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of Crtc1/3-Maml2 fusion status, grade and survival in mucoepidermoid carcinoma.
    Birkeland AC; Foltin SK; Michmerhuizen NL; Hoesli RC; Rosko AJ; Byrd S; Yanik M; Nor JE; Bradford CR; Prince ME; Carey TE; McHugh JB; Spector ME; Brenner JC
    Oral Oncol; 2017 May; 68():5-8. PubMed ID: 28438292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRTC1-MAML2 fusion in mucoepidermoid carcinoma of the breast.
    Bean GR; Krings G; Otis CN; Solomon DA; García JJ; van Zante A; Camelo-Piragua S; van Ziffle J; Chen YY
    Histopathology; 2019 Feb; 74(3):463-473. PubMed ID: 30380176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucoepidermoid carcinoma of the cervix: another tumor with the t(11;19)-associated CRTC1-MAML2 gene fusion.
    Lennerz JK; Perry A; Mills JC; Huettner PC; Pfeifer JD
    Am J Surg Pathol; 2009 Jun; 33(6):835-43. PubMed ID: 19092631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of CRTC1/3-MAML2 fusions in salivary gland mucoepidermoid carcinoma: A multiinstitutional retrospective study.
    Okumura Y; Nakano S; Murase T; Ueda K; Kawakita D; Nagao T; Kusafuka K; Urano M; Yamamoto H; Kano S; Tsukahara K; Okami K; Nagao T; Hanai N; Iwai H; Kawata R; Tada Y; Nibu KI; Inagaki H
    Cancer Sci; 2020 Nov; 111(11):4195-4204. PubMed ID: 32860299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of CRTC1/MAML2 Translocation in the Prognosis and Clinical Outcomes of Mucoepidermoid Carcinoma.
    Saade RE; Bell D; Garcia J; Roberts D; Weber R
    JAMA Otolaryngol Head Neck Surg; 2016 Mar; 142(3):234-40. PubMed ID: 26796488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Grade Transformation in Mucoepidermoid Carcinoma of the Minor Salivary Gland with Polyploidy of the Rearranged MAML2 Gene.
    Lee H; Roh JL; Choi YJ; Choi J; Cho KJ
    Head Neck Pathol; 2020 Sep; 14(3):822-827. PubMed ID: 31535311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of p27Kip1, Ki-67, and CRTC1-MAML2 fusion transcript in mucoepidermoid carcinoma: a molecular and clinicopathologic study of 101 cases.
    Miyabe S; Okabe M; Nagatsuka H; Hasegawa Y; Inagaki A; Ijichi K; Nagai N; Eimoto T; Yokoi M; Shimozato K; Inagaki H
    J Oral Maxillofac Surg; 2009 Jul; 67(7):1432-41. PubMed ID: 19531414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary mucoepidermoid carcinoma of the liver with CRTC1-MAML2 fusion: a case report.
    Watanabe J; Kai K; Tanikawa K; Hiraki M; Mizukami N; Aishima S; Nakano T; Yamamoto H
    Diagn Pathol; 2019 Jul; 14(1):84. PubMed ID: 31351495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salivary mucoepidermoid carcinoma: histological variants, grading systems, CRTC1/3-MAML2 fusions, and clinicopathological features.
    Nakano S; Okumura Y; Murase T; Nagao T; Kusafuka K; Urano M; Yamamoto H; Kano S; Tsukahara K; Okami K; Kawakita D; Nagao T; Hanai N; Iwai H; Kawata R; Tada Y; Nibu KI; Inagaki H
    Histopathology; 2022 Mar; 80(4):729-735. PubMed ID: 34657306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gefitinib as targeted therapy for mucoepidermoid carcinoma of the lung: possible significance of CRTC1-MAML2 oncogene.
    O'Neill ID
    Lung Cancer; 2009 Apr; 64(1):129-30. PubMed ID: 19185385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Notch and EGFR signaling in human mucoepidermoid carcinoma.
    Ni W; Chen Z; Zhou X; Yang R; Yu M; Lu J; Kaye FJ; Wu L
    Signal Transduct Target Ther; 2021 Jan; 6(1):27. PubMed ID: 33473104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of CRTC1-MAML2 translocation in salivary mucoepidermoid carcinoma: Systematic review and meta-analysis.
    Pérez-de-Oliveira ME; Wagner VP; Araújo ALD; Martins MD; Santos-Silva AR; Bingle L; Vargas PA
    J Oral Pathol Med; 2020 May; 49(5):386-394. PubMed ID: 31661572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.